Herpes zoster infection
BMJ Best Practice Podcast
00:00
Preventing Post-Teropatic Neuroalgia
A zoster vaccine can reduce the probability of post-teropatic neuroalgia by about two thirds. The problem was that after about 10 years all that protection seems to be lost and so patients would require a re-vaccination probably before 10 years because when you get to 10 years it's completely gone. A newer vaccine which is not a live vaccine it's a subunit of a zoster with an adjuvant has been found to be more than 90% effective even in older patients whose immune systems are more vulnerable.
Transcript
Play full episode
